Our approach

Formulations with exceptional stability, offered in multiple presentations

Formulation options

Jurata’s formulations preserve the activity of biologic materials by stabilizing their three-dimensional structure. Initially applied to gene therapies and vaccines, our technology has now shown promise across a broad range of cargoes. The ability to maintain efficacy has been demonstrated at ambient and elevated temperatures.

The same novel material forms the basis of both of Jurata formulation types:

Liquid

The liquid presentation can be filled in vials or any standard administration device (e.g, autoinjector pen). Intravenous, intramuscular, and subcutaneous injection administration routes are all enabled, as is oral administration.

Film

Films can be used directly for sublingual, buccal, or oral administration, or can be reconstituted for use as a liquid. A key benefit of the film presentation is its light weight and small footprint, enabling cost-savings in shipping and storage.

Benefits of Our Formulations

A transformation in the manufacturing, distribution, and administration of vaccines and biologics

  • Medicines can be shipped to pharmacies, patients’ homes, or to remote global locations without loss of efficacy or compromised quality; once delivered, patients and providers do not need to worry about maintaining temperature control.

  • Jurata’s stability benefits are available regardless of presentation, allowing choice of administration route to optimize each medicine.

    • Oral, intranasal, sublingual, and buccal administration open up possibilities for needle-free solutions that don’t require specialized healthcare personnel or office visits.

    • Liquid formulations can be used for all types of injectable administration, enabling improvements in manufacturing, shipping, and storage without changes to established medical routines.

  • Jurata provides optionality by tailoring development for stability and efficacy across liquid and film presentations without the need for API lyophilization.

Proven across multiple modalities

Jurata formulations stabilize vaccines, biologics, gene therapies, and other APIs.

  • Live Attenuated Vaccines

  • Inactivated Vaccines

  • Recombinant Vaccines

  • Subunit Vaccines

  • VLPs

  • Toxoid Vaccines

  • Viral and Bacterial Platforms

  • Antibodies/Antibody-Enzyme Conjugate

  • Plasmid DNA

  • Peptides

  • Proteins

Let's Get Started